China Pharma (CPHI) Competitors $1.63 +0.04 (+2.52%) Closing price 04:00 PM EasternExtended Trading$1.61 -0.02 (-1.29%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CPHI vs. FNCH, SXTC, OVID, NAII, SLGL, BIVI, CGTX, CMMB, ASBP, and LGVNShould you be buying China Pharma stock or one of its competitors? The main competitors of China Pharma include Finch Therapeutics Group (FNCH), China SXT Pharmaceuticals (SXTC), Ovid Therapeutics (OVID), Natural Alternatives International (NAII), Sol-Gel Technologies (SLGL), BioVie (BIVI), Cognition Therapeutics (CGTX), Chemomab Therapeutics (CMMB), Aspire Biopharma (ASBP), and Longeveron (LGVN). These companies are all part of the "pharmaceutical products" industry. China Pharma vs. Its Competitors Finch Therapeutics Group China SXT Pharmaceuticals Ovid Therapeutics Natural Alternatives International Sol-Gel Technologies BioVie Cognition Therapeutics Chemomab Therapeutics Aspire Biopharma Longeveron China Pharma (NYSE:CPHI) and Finch Therapeutics Group (NASDAQ:FNCH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability. Do institutionals & insiders have more ownership in CPHI or FNCH? 21.8% of Finch Therapeutics Group shares are held by institutional investors. 17.3% of China Pharma shares are held by insiders. Comparatively, 44.9% of Finch Therapeutics Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in CPHI or FNCH? Finch Therapeutics Group received 10 more outperform votes than China Pharma when rated by MarketBeat users. Likewise, 52.63% of users gave Finch Therapeutics Group an outperform vote while only 0.00% of users gave China Pharma an outperform vote. CompanyUnderperformOutperformChina PharmaOutperform VotesNo VotesUnderperform Votes94100.00% Finch Therapeutics GroupOutperform Votes1052.63% Underperform Votes947.37% Which has preferable earnings & valuation, CPHI or FNCH? China Pharma has higher revenue and earnings than Finch Therapeutics Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChina Pharma$4.30M1.24-$3.08MN/AN/AFinch Therapeutics Group$110K200.75-$74.75M-$8.82-1.56 Does the media favor CPHI or FNCH? In the previous week, China Pharma had 1 more articles in the media than Finch Therapeutics Group. MarketBeat recorded 1 mentions for China Pharma and 0 mentions for Finch Therapeutics Group. China Pharma's average media sentiment score of 0.88 beat Finch Therapeutics Group's score of 0.00 indicating that China Pharma is being referred to more favorably in the media. Company Overall Sentiment China Pharma Positive Finch Therapeutics Group Neutral Is CPHI or FNCH more profitable? Finch Therapeutics Group has a net margin of 0.00% compared to China Pharma's net margin of -85.56%. China Pharma's return on equity of -63.93% beat Finch Therapeutics Group's return on equity.Company Net Margins Return on Equity Return on Assets China Pharma-85.56% -63.93% -31.42% Finch Therapeutics Group N/A -69.14%-26.92% Which has more volatility and risk, CPHI or FNCH? China Pharma has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Finch Therapeutics Group has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. SummaryFinch Therapeutics Group beats China Pharma on 8 of the 13 factors compared between the two stocks. Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CPHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPHI vs. The Competition Export to ExcelMetricChina PharmaPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$5.32M$6.85B$5.56B$19.63BDividend YieldN/A2.53%5.28%3.82%P/E RatioN/A8.4326.6435.03Price / Sales1.24262.52407.9942.85Price / CashN/A65.8538.2517.51Price / Book2.336.536.974.78Net Income-$3.08M$143.25M$3.23B$1.02B7 Day Performance1.05%0.21%-0.98%-0.35%1 Month Performance-22.38%10.92%7.70%1.04%1 Year Performance-93.76%2.44%31.32%9.19% China Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPHIChina Pharma0.7999 of 5 stars$1.63+2.5%N/A-94.1%$5.32M$4.30M0.00250Short Interest ↓FNCHFinch Therapeutics Group0.3434 of 5 stars$13.60+0.7%N/A+861.2%$21.84M$110K-1.54190Gap UpSXTCChina SXT Pharmaceuticals0.3801 of 5 stars$1.32-5.0%N/A-77.4%$20.89M$1.82M0.0090Positive NewsShort Interest ↑Gap DownOVIDOvid Therapeutics4.3823 of 5 stars$0.29+6.5%$2.78+860.1%-91.0%$20.62M$548K-0.6260NAIINatural Alternatives International0.7738 of 5 stars$3.31-0.4%N/A-47.7%$20.43M$125.48M-2.56290News CoverageShort Interest ↑SLGLSol-Gel Technologies3.005 of 5 stars$7.32+1.5%$40.00+446.7%-11.5%$20.38M$12.10M-21.5250Positive NewsShort Interest ↓BIVIBioVie2.4348 of 5 stars$1.07+2.9%$3.00+180.4%+142.1%$19.86MN/A-0.1110CGTXCognition Therapeutics3.64 of 5 stars$0.32+32.6%$5.63+1,674.4%-87.1%$19.65MN/A-0.3320Short Interest ↓Gap UpHigh Trading VolumeCMMBChemomab Therapeutics3.5673 of 5 stars$1.35+2.3%$8.50+529.6%+11.4%$19.39MN/A-1.3520Positive NewsASBPAspire BiopharmaN/A$0.39-10.5%N/AN/A$19.07MN/A0.00N/ANews CoverageGap DownLGVNLongeveron3.5097 of 5 stars$1.25+0.8%$8.67+593.3%-27.1%$18.66M$2.23M-0.2020Gap Down Related Companies and Tools Related Companies Finch Therapeutics Group Competitors China SXT Pharmaceuticals Competitors Ovid Therapeutics Competitors Natural Alternatives International Competitors Sol-Gel Technologies Competitors BioVie Competitors Cognition Therapeutics Competitors Chemomab Therapeutics Competitors Aspire Biopharma Competitors Longeveron Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CPHI) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CPHI Stock Free CPHI Stock Alerts